新冠疫情下头颈癌放疗:意大利米兰经验报告
该研究报道了意大利米兰在新冠疫情早期(2020年3月1日至4月30日)一家放疗科针对头颈癌患者的组织管理策略,包括专用流程、放疗排程和医护人员防护。结论认为合理及时的组织安排能在最大可能范围内平衡患者照护与人员安全。
要点
- 16%患者因疑似新冠感染中断或延迟放疗。
- 2名管理头颈癌患者的医护人员新冠检测阳性。
核心结论
- 合理且及时的组织安排有助于在疫情下优化头颈癌放疗,并最大可能平衡患者照护与人员安全。
研究设计与样本
- 回顾性报告,描述意大利米兰一家放疗科在2020年3月1日至4月30日新冠疫情期间针对头颈癌的专用流程、放疗排程和医护人员防护措施。
主要发现
- 中位总治疗时间为50天(四分位距47-54.25天)。
- 7例患者(16%)因疑似新冠感染中断或延迟放疗。
- 2名管理头颈癌患者的医护人员新冠检测阳性。
临床怎么用
- 在疫情等突发公共卫生事件中,可参考该中心的专用流程、放疗排程和防护策略来组织头颈癌放疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management of head and neck cancers (HNC) in radiation oncology in the coronavirus disease 2019 (COVID-19) era is challenging. Aim of our work is to report organization strategies at a radiation therapy (RT) department in the first European area experiencing the COVID-19 pandemic. METHODS: We focused on (a) dedicated procedures for HNC, (b) RT scheduling, and (c) health care professionals' protection applied during the COVID-19 breakdown (from March 1, 2020 to April 30, 2020). RESULTS: Applied procedures are reported and discussed. Forty-three patients were treated. Image-guided, intensity modulated RT was performed in all cases. Median overall treatment time was 50 (interquartile range: 47-54.25) days. RT was interrupted/delayed in seven patients (16%) for suspected COVID-19 infection. Two health professionals managing HNC patients were proven as COVID-19 positive. CONCLUSION: Adequate and well-timed organization allowed for the optimization of HNC patients balancing at the best of our possibilities patients' care and personnel's safety.
引用
- Alterio D, Volpe S, Marvaso G, et al. Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy. Head Neck. 2020. PMID: 32557972. doi:10.1002/hed.26319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。